Physician profile
Alexa Rouse Thomas
NPI 1629578661
$760.70
in general payments reported to CMS, 2019-2025
18 companies · $433 in 2025
The $433 reported for 2025 was more than what 77% of Surgical providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $29.59 · 2024: $298 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $760.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $149.84 | 2024 | Endurant Iis |
| W. L. Gore & Associates, INC. | $134.58 | 2025 | Gore Excluder Iliac Branch Endoprosthesis |
| Atricure, INC. | $61.25 | 2025 | Atricure Cryoice Cryosphere Cryoablation System, Synergy Ablation System |
| Endologix LLC | $50.63 | 2023-2024 | Afx2 Bifurcated Endograft System, Ovation Ix Iliac Stent Graft |
| Peerless Surgical INC. | $42.27 | 2024 | |
| Merck Sharp & Dohme LLC | $33.79 | 2024 | Keytruda |
| Bard Peripheral Vascular, INC. | $31.19 | 2025 | Venovo |
| Baxter Healthcare | $30.94 | 2025 | Preveleak |
| Getinge USA Sales, LLC | $30.14 | 2025 | Intergard |
| Davol INC. | $29.76 | 2025 | |
| Terumo Medical Corporation | $27.97 | 2025 | Azur Cx Detachable |
| Acera Surgical, INC. | $24.98 | 2025 | Restrata Wound Matrix |
| Cvrx, INC. | $21.45 | 2025 | Barostim Neo System |
| Lemaitre Vascular, INC. | $20.61 | 2025 | Restoreflow |
| Convatec INC. | $20.00 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $19.94 | 2025 | Collagenase Santyl |
| Solventum Corporation | $17.36 | 2024 | Prevena |
| Abbott Laboratories | $14.00 | 2023 | Diamondback Peripheral |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.